Georges Imbert

3.5k citations

17 papers · 2.8k indexed · 3 hit papers · h-index 11

Impact in

Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases
Neurology top 1%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments

Papers in ⓘ

Molecular Biology 10
- Mitochondrial Function and Pathology 6
- Ion channel regulation and function 1
Cellular and Molecular Neuroscience 8
- Genetic Neurodegenerative Diseases 7

Co-authors: Jean‐Louis Mandel (8 shared papers)Yves Agid (5 shared papers)Frédéric Saudou (5 shared papers)C. R. Weber (4 shared papers)Yvon Trottier (5 shared papers)Didier Devys (4 shared papers)Géraldine Cancel‐Tassin (4 shared papers)Giovanni Stévanin (4 shared papers)
Journals: Nature Genetics (4 papers)Alzheimer s & Dementia (3 papers)Neurogenetics (1 paper)Analytical Chemistry (1 paper)Drug Discovery Today (1 paper)
Partner nations: France Switzerland United States

In The Last Decade

Georges Imbert

17 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion 1997 · 599 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1997 Nature Genetics
1996 Nature Genetics
1995 Nature

Peers

Countries citing papers authored by Georges Imbert

Since Specialization

Citations

This map shows the geographic impact of Georges Imbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Imbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Imbert more than expected).

Fields of papers citing papers by Georges Imbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georges Imbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Imbert. The network helps show where Georges Imbert may publish in the future.

Co-authors

The 25 scholars most cited alongside Georges Imbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Georges Imbert Line = papers co-authored together Georges Imbert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats Nature Genetics ·Georges Imbert, Frédéric Saudou, Gaël Yvert, Didier Devys, Yvon Trottier, Jean‐Marie Garnier, C. R. Weber, Jean‐Louis Mandel, Géraldine Cancel‐Tassin, Nacer Abbas, Alexandra Dürr, Olivier Didierjean, Giovanni Stévanin, Yves Agid, Alexis Brice Hit paper breakdown →	1996	706
2	Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion Nature Genetics ·Gilles David, Nacer Abbas, Giovanni Stévanin, Alexandra Dürr, Gaël Yvert, Géraldine Cancel‐Tassin, C. R. Weber, Georges Imbert, Frédéric Saudou, Eric Antoniou, Harry A. Drabkin, Robert M. Gemmill, Paola Giunti, Ali Benomar, Nicholas Wood, Merle Ruberg, Yves Agid, Jean‐Louis Mandel, Alexis Brice Hit paper breakdown →	1997	599
3	Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias Nature ·Yvon Trottier, Yves Lutz, Giovanni Stévanin, Georges Imbert, Didier Devys, Géraldine Cancel‐Tassin, Frédéric Saudou, C. R. Weber, Gilles David, Làszlò Tora, Yves Agid, Alexis Brice, Jean‐Louis Mandel Hit paper breakdown →	1995	540
4	Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form Nature Genetics ·Yvon Trottier, Didier Devys, Georges Imbert, Frédéric Saudou, Isabelle An, Yves Lutz, C. R. Weber, Yves Agid, Étienne C. Hirsch, Jean‐Louis Mandel	1995	348
5	Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study The Lancet Neurology ·Bengt Winblad, Niels Andreasen, Lennart Minthon, Annette Floesser, Georges Imbert, Thomas Dumortier, R. P. Maguire, Kaj Blennow, Joens Lundmark, Matthias Staufenbiel, Jean‐Marc Orgogozo, Ana Graf	2012	234
6	Origin of the expansion mutation in myotonic dystrophy Nature Genetics ·Georges Imbert, Christine Kretz, Keith Johnson, Jean‐Louis Mandel	1993	168
7	Controlled Protein Precipitation in Combination with Chip-Based Nanospray Infusion Mass Spectrometry. An Approach for Metabolomics Profiling of Plasma Analytical Chemistry ·K. Olaf Boernsen, Stephan Gatzek, Georges Imbert	2005	75
8	Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region American Journal of Medical Genetics ·Yvon Trottier, Georges Imbert, Annemarie Poustka, Jean‐Pierre Fryns, Jean‐Louis Mandel	1994	38
9	The human small conductance calcium-regulated potassium channel gene ( hSKCa3 ) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia Neurogenetics ·Oliver H. Wittekindt, Anna Jauch, E. Omer Burgert, L.O. Schärer, Heidi Holtgreve-Grez, Gaël Yvert, Georges Imbert, Jürgen Zimmer, Margret R. Hoehe, Jean-Paul Macher, Pierre Chiaroni, Dietrich van Calker, Marc‐Antoine Crocq, Déborah Morris-Rosendahl	1998	35
10	Differential distribution of the normal and mutated forms of huntingtin in the human brain Annals of Neurology ·Isabelle Gourfinkel‐An, Géraldine Cancel‐Tassin, Yvon Trottier, Didier Devys, Làszlò Tora, Yves Lutz, Georges Imbert, Frédéric Saudou, Giovanni Stévanin, Yves Agid, Alexis Brice, Jean‐Louis Mandel, Étienne C. Hirsch	1997	32
11	Dose‐dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship Epilepsia ·Dorothée Kasteleijn‐Nolst Trenité, Christian Brandt, (unknown), Felix Rosenow, Bernd Schmidt, Bernhard J. Steinhoff, Anne Gardin, Georges Imbert, Donald R. Johns, Alexandros Sagkriotis, Klaus Kucher	2015	23
12	The fragile X mutation Mental Retardation and Developmental Disabilities Research Reviews ·Georges Imbert, Jean‐Louis Mandel	1995	7
13	P2‐083: Aβ‐specific antibodies induced by active immunotherapy CAD106 engage Aβ in plasma in AD patients Alzheimer s & Dementia ·Bengt Winblad, Martin R. Farlow, Kaj Blennow, Igor Voštiar, Georges Imbert, Andrija Tomović, Peter Quarg, Marie‐Emmanuelle Riviere, Niels Andreasen, Ana Graf	2011	3
14	P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients Alzheimer s & Dementia ·Ana Graf, Niels Andreasen, Marie‐Emmanuelle Riviere, Jacqueline Ros, Jessie Moreau, Jeffrey Sevigny, Peter Quarg, Angelika Caputo, Luca A. Finelli, Bengt Winblad, Georges Imbert	2010	2
15	P3‐285: Antibody immune response in cynomolgus monkeys following treatment with the active Aß immunotherapy CAD106 Alzheimer s & Dementia ·Georges Imbert, Séverine Marrony, Peter Ulrich, Paul Goldsmith	2009	2
16	Democratizing data at Novartis through clinical trial data access Drug Discovery Today ·Gabriel S. Eichler, Georges Imbert, Janice Branson, Rene Balibey, Jason M. Laramie	2022	1
17	Impact of co-administration of fevipiprant (QAW039) and SLCO1B1 genotype on the PK of simvastatin and rosuvastatin Avantika Barve, Hanns-Christian Tillmann, Emma Ilsley, Janardhana Vemula, Alexandra Nica, Georges Imbert, Walid Elbast, Hilmar Schiller, Gian Camenisch, Ralph Woessner	2016	1

About Georges Imbert

Georges Imbert is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Neurology, Physiology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 2.8k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (7 papers), Mitochondrial Function and Pathology (6 papers), Alzheimer's disease research and treatments (4 papers), Neurological disorders and treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Genetics and Neurodevelopmental Disorders (3 papers), Pharmaceutical Economics and Policy (2 papers) and Ion channel regulation and function (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (2.2k citations), Neurology (860 citations), Molecular Biology (2.3k citations), Neurology (182 citations) and Biological Psychiatry (46 citations). Georges Imbert has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Jean‐Louis Mandel, Yves Agid, Frédéric Saudou, C. R. Weber, Yvon Trottier, Didier Devys, Géraldine Cancel‐Tassin, Giovanni Stévanin, Alexis Brice and Gaël Yvert. Their work appears in journals such as Nature Genetics, Alzheimer s & Dementia, Neurogenetics, Analytical Chemistry and Drug Discovery Today.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact